A field-ready record for provider due diligence
A printable, factual framework for documenting what a Cancún ibogaine provider can verify—and what remains unanswered before anyone treats a program as a serious option.
How to use this template
Open one dossier for each provider. Write down the source for every answer: a public registry result, a dated document, a direct written response, or a conversation note. Separate claims from materials you can independently confirm.
This companion to the Cancún vetting checklist is designed for prospective patients, families, and support people who need a consistent way to compare claims without mistaking presentation for proof.
Ibogaine has recognized pharmacologic effects and potential risks; the general overview of ibogaine’s pharmacology and use history is not a substitute for individualized clinical assessment, but it helps explain why a detailed record matters.
The first record set
Begin with details that can be checked outside the provider’s own materials. A missing answer is itself dossier information; do not fill gaps with assumptions.
Record the entity name used in contracts, its physical treatment address, named legal representative if supplied, and every public-facing name used by the program. Ask whether the treatment location and contracting entity are the same.
Request the full name, professional role, license number, scope of responsibility, and whether that person is physically present during dosing and recovery. Do not treat a biography alone as confirmation.
Use Mexico’s official professional license registry to search a supplied license number or name, then preserve the search date and result in the dossier.
Annotate the clinical record
Ask for an on-site equipment inventory, not a general statement that “medical support” is available. Note whether the response identifies ECG capability, oxygen, suction, defibrillation capability, emergency medications, qualified monitoring staff, and how equipment is checked and maintained.
For cardiac monitoring, request the written monitoring protocol and blank or redacted examples of logs: what is monitored, how often entries are made, who reviews them, and what triggers escalation. The cardiac safety guide can help keep these questions centered on documented screening, observation, and response rather than broad safety claims.
Emergency transfer claims should include the receiving hospital name, distance or expected route, contact point, transport plan, and the current written agreement or a clear explanation if no agreement exists. Mexico’s federal health authority, Secretaría de Salud, is a useful starting point for understanding the public health context; it does not validate an individual provider for you.
“Available if needed” is not the same as a named plan, a responsible person, and a documented pathway.
Questions worth keeping in writing
Ask for the language versions of informed-consent materials, the point when participants receive them, the risks described, and who explains them. Document whether translation is professional, whether there is time to ask questions, and whether the materials identify post-treatment limits and escalation steps.
Request the provider’s method for recording adverse events and patient outcomes. A useful answer identifies definitions, time period, who collects the information, whether records are reviewed, and what is made available to prospective patients. General research standards emphasize transparent methods and participant protections; the U.S. human-subject protections framework illustrates why consent and documentation deserve more than verbal treatment.
Include any insurance, indemnity, waiver, refund, or limitation-of-liability documents in the dossier. These documents should be read carefully before travel or payment. The broader context in Mexican ibogaine center comparisons may reveal questions to repeat consistently, while a separate treatment facility overview can help distinguish a claimed service from a documented operating practice.
Independent reference checks
Reputation can surface concerns, but praise, testimonials, and a polished online presence do not establish clinical readiness. Keep the source, date, and any conflicting information together.
Search the provider’s legal entity name, key names supplied by the provider, facility names, and prior brand names. Record the publication or court source, date, allegation or finding, provider response if available, and whether the information can be independently corroborated.
Ask for independent references and note the relationship between the reference and provider. Compare recurring details across conversations rather than relying on one account. Perspectives such as ibogaine trip experiences may identify practical questions, but personal reports are not verification of a program’s medical claims.
Use comparisons carefully. A resource on ibogaine options in Canada may show how jurisdiction, access, and oversight differ, while what ibogaine does can help clarify why claims about outcomes should be separated from evidence. Programs connecting ibogaine with other identities or communities—including material on ibogaine and martial arts—should still be assessed through the same factual fields.
For a structured overview of questions to carry across locations, return to Coral Triage’s Cancún evaluation framework. If you want to understand the standards behind this resource, the independent due-diligence approach explains the emphasis on documented answers, uncertainty, and informed consent.
Keep personal medical questions separate from provider research. Some people also encounter advocacy or education material such as ibogaine and MMA perspectives; it may be relevant to their context, but it does not replace a qualified clinician’s individualized assessment.
A clear boundary
This template is for informational due diligence only. It is not medical advice, legal advice, a safety certification, or an endorsement of any provider. A complete-looking dossier does not remove risk, and unresolved questions should remain visible rather than being explained away.
See the evaluation resources